Learn More
Medchemexpress LLC (E)-2-Cyano-3-(3,4-dihydroxyphenyl)-N-(4-phenylbutyl)-2-propenamide | 133550-41-1 | 99.9% | 336.39 g/mol | C20H20N2O3 | 10 MG

Supplier: Medchemexpress LLC HY10104110MG
(E)-AG 556 is a research-grade small-molecule inhibitor of the epidermal growth factor receptor (EGFR). It is highly selective for EGFR kinase activity and has been reported to block lipopolysaccharide (LPS)-induced tumor necrosis factor-alpha (TNF-α) production. The compound is supplied as a solid with high reported purity and is typically dissolved in DMSO for in vitro studies.
- Highly selective EGFR tyrosine kinase inhibitor.
- Reported to block LPS-induced TNF-α production.
- High purity (reported ~99.9%).
- Solid, light yellow to yellow appearance.
- Soluble in DMSO for preparation of stock solutions.
- Suitable for cell-based and biochemical assays.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.